To-Do List for 2009 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

To-Do List for 2009
Planning ahead will ensure successful efforts to improve packaging and packaging operations.


Pharmaceutical Technology
Volume 32, Issue 10


TETRA IMAGES/GETTY IMAGES
The new year is approaching fast, and it's not too early to think about goals for 2009. Although they differ from person to person and from job to job, three goals should be on every packaging team's list for 2009: improving the sustainability of its package or packaging line; identifying and implementing a container, material, machine, or practice that could improve its packaging process; and considering ways to make its packaging more consumer-friendly.


Hallie Forcinio
No matter which goal a team pursues, taking time to plan strategies and tactics in advance will help ensure that it is achieved.

Sustainability

It's important to periodically compare package designs with the reduce, reuse, recycle hierarchy that the Environmental Protection Agency advocates. For example, designers should ask whether the product's efficacy depends on the weight of the package. Even the smallest reduction in material thickness or weight can significantly decrease material costs, transportation costs, and greenhouse-gas emissions (see "Sustainability Surprises" in the September 2008 issue of Pharmaceutical Technology).

Designers should also ask whether the package must be as large as it is. Shrinking the size of a primary package, even by a millimeter or two, not only reduces weight, but also decreases the size of secondary and tertiary packaging. This reduction allows more product to be stacked per pallet, potentially making a difference throughout the supply chain.


Plastic-identification recycling codes help consumers increase recycling rates. PETE is polyethylene terephthalate, HDPE is high-density polyethylene, V is vinyl, LDPE is low-density polyethylene, PP is polypropylene, and PS is polystyrene. (IMAGE IS COURTESY OF THE SOCIETY OF THE PLASTICS INDUSTRY.)
Another criterion to evaluate is whether the package contains recycled content. If it does, perhaps more recycled content can be added. If recycled content is present, that fact should be noted on the package for consumers.

Fiber-based materials such as corrugated shipping cases, paperboard folding cartons, and paper-based labels, lidstock, and inserts or outserts should be made from certified material. Third-party certifications to the standards of organizations such as the Forest Stewardship Council and Sustainable Forestry Initiative confirm that the pulp used in the packagingproduction process comes from responsibly managed forests.

Packagers should seek to identify the biggest source of waste on the packaging line and discover how waste could be reduced. If preprinted material is the biggest source of waste, converting to a print-on-demand process might be cost-effective. Print-on-demand equipment is commonly available and includes various types of coders (e.g., laser, inkjet, and thermal-transfer) as well as label printers and applicators. Some units also can incorporate radiofrequency-identification-tag encoding modules to help drugmakers meet pedigree requirements.

If the package is not commonly recycled, packagers should find ways to improve its recycling rate. When recycling, consumers tend to focus on packaging for foods and beverages and overlook containers for other products, which are equally acceptable in many collection programs. Perhaps consumers should be reminded about the container's recyclability through a message on the label or a recycling logo on the base of the package.

The infrastructure supporting the collection of used packaging for recycling needs to be improved. Many trade associations are working to boost recycling rates. In addition, companies such as Estée Lauder's Aveda and TerraCycle have established creative programs to keep packaging material out of landfills.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here